Bristol-Myers Squibb Company (BMY.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
As of 07:30AM CST. Market open.
| Previous close | 729.00 |
| Open | 701.50 |
| Bid | 699.02 x 1400 |
| Ask | 722.39 x 3800 |
| Day's range | 701.30 - 701.50 |
| 52-week range | 701.30 - 1,173.00 |
| Volume | |
| Avg. volume | 3,627 |
| Market cap | 1.422T |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 41.17 (5.65%) |
| Ex-dividend date | 04 Apr 2024 |
| 1y target est | N/A |
- Associated Press Finance
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
A Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication, the state attorney general said Tuesday. The judgement was issued against Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi. Bristol Myers Squibb and Sanofi said in a joint statement they disagreed with the penalty and plan to appeal.
- Simply Wall St.
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...
- Zacks
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.